Upload
others
View
2
Download
1
Embed Size (px)
Citation preview
First world conference onluteinizing hormone in assistedreproductive technology27-28 May 2016 - Naples, Italy
INTERNATIONAL CONFERENCEPRELIMINARY PROGRAMME
1
OverviewThe role of luteinizing hormone (LH) during folliculogenesis hasheightened curiosity for at least three decades. In particular, thescientific community is still divided over recognizing the relevance ofLH containing drugs during controlled ovarian stimulation (COS).Availability of recombinant drugs has offered, for the first time, theopportunity to explore the role of the follicle stimulating hormone(FSH) and luteinizing hormone (LH) separately. Despite thisopportunity, the role of recombinant LH is still a matter of debate.What recently emerged is that LH is actively able to improve theoutcome of IVF in specific subgroup of patients, including advancedage women (>35 years old) and the so-called “hypo-responders”. Thelatter group is represented by subjects that, despite being young,having normal ovarian reserve, and being classified asnomonadotrophic, show “slow” and sub-optimal response toconventional FSH doses. It was estimated that the profile of ovarianresponse is evident in 10-12% of women undergoing COS. Moreinterestingly, the increase in ongoing pregnancy rates in these twosubgroups of women does not seem to be correlated with the numberof oocytes, suggesting that improvement in oocyte quality and/orextragonadal effects of LH could be implicated. Although a growingbody of evidence is defining the role of LH during COS, clear guidelinesand practical recommendations on this aspect are lacking.
This conference will show evidence from basic science to clinicalpractice regarding the use of recombinant LH and will illustrate itspossible benefits as well as its physiopathological mechanism. Guidedby an expert, participants will grasp the rationale for usingrecombinant LH in assisted reproductive technology as well asunderstand the role of LH in human reproduction.
Learning objectivesBy attending this live educational conference, participants will be able to:• Understand the physiology of LH and its role in ovulation induction• Grasp the state of the art regarding the use of recombinant LH use • Individualise groups of patients that required LH duringstimulation protocols
• Identify specific ovarian reserve markers and genotypepolymorphism useful for tailoring treatments and choosing thebest approach
Target audienceThis programme is intended for clinicians, embryologists, biologistsand scientists working in ART.
Honorary PresidentGiuseppe De PlacidoUniversity of Naples " Federico II" NaplesNaples, Italy
ChairsCarlo AlviggiUniversity of Naples " Federico II" NaplesNaples, Italy
Sandro C. EstevesANDROFERT - Andrology & Human Reproduction Clinic São Paulo, Brazil
Local scientific committee
Coordinator
Ida StrinaUniversity of Naples " Federico II" NaplesNaples, Italy
Luisa AvinoUniversity of Naples " Federico II" NaplesNaples, Italy
Alessandro ConfortiUniversity of Naples " Federico II" NaplesNaples, Italy
Pasquale De RosaUniversity of Naples " Federico II" NaplesNaples, Italy
Silvia PicarelliUniversity of Naples " Federico II" NaplesNaples, Italy
Roberta ValloneUniversity of Naples " Federico II" NaplesNaples, Italy
2
CME ProviderEXCEMED is a non profit foundation dedicated, since the last fourdecades, to the development of high-quality medical educationprogramme all over the world.
EXCEMED adheres to the guidelines and standards of the EuropeanAccreditation Council for Continuing Medical Education (EACCME®)which states that continuing medical education must be balanced,independent, objective, and scientifically rigorous.
Continuing medical educationAn application has been made to the EACCME® for CME accreditationof the EXCEMED conference “First world conference on luteinizinghormone in assisted reproductive technology” to be held on 27-28May 2016 in Naples, Italy.
The CME conference “First world conference on luteinizing hormonein assisted reproductive technology” to be held on 27-28 May 2016 inNaples, Italy will be submitted for CME accreditation from the ItalianMinistry of Health.
EXCEMED adheres to the principles of the Good CME Practice group(gCMEp).
3
Carlo AlviggiUniversity of Naples " Federico II" NaplesNaples, Italy
Claus Yding AndersenUniversity Hospital of CopenhagenCopenhagen, Denmark
Manish BankerNova IVI FertilityPulse Women's HospitalGujarat, India
Ernesto BoschInstituto Valenciano de Infertilidad Valencia, Spain
Klaus BühlerCentre for Gynaecological Endocrinology and Reproductive MedicineStuttgart, Germany
Nicola ColacurciOutpatient Fertility ClinicSecond University of NaplesNaples, Italy
Sandro C. EstevesANDROFERT - Andrology & Human Reproduction Clinic São Paulo, Brazil
Renato FanchinHospital A. Béclère and University Paris-SudClamart, France
Annapia Ferraretti SISMeR, Società Italiana Studi di Medicina della Riproduzione Bologna, Italy
Robert FischerFertility Centre HamburgHamburg, Germany
6
Ilpo HuhtaniemiInstitute of Reproductive and Developmental BiologyHammersmith Campus, Imperial College LondonLondon, UK
Peter HumaidanFertility ClinicSkive Regional Hospital, and Faculty of HealthAarhus UniversityAarhus, Denmark
Antonio La MarcaUniversity of Modena and Reggio Emilia and Clinica EuginModena, Italy
Raoul OrvietoInfertility and IVF UnitDepartment of Obstetrics and GynaecologyThe Chaim Sheba Medical CenterTel Hashomer, Israel
Nikolaos PolyzosVrije Universiteit BrusselCenter for Reproductive MedicineUniversitair Ziekenhuis BrusselBrussels, Belgium
Eleonora PorcuDepartment of Medical and Surgical SciencesUniversity of BolognaBologna, Italy
Manuela SimoniUniversity of Modena and Reggio EmiliaModena, Italy
Sesh K. SunkaraAberdeen Fertility CentreAberdeen Maternity HospitalAberdeen, UK
Fulvio ZulloReggio Calabria UniversityCatanzaro, Italy
7
Programme
Friday, 27 May 2016
From 12.00 RegistrationWelcome Lunch
13.30 EXCEMED Opening R. Fischer (Germany)
13.40 Local WelcomeG. De Placido (Italy)
13.50 IntroductionC. Alviggi (Italy) - S.C. Esteves (Brazil)
Chairs: R. Fisher (Germany) - E. Porcu (Italy)
14.00 L1: Physiology of LH and differences with hCGM. Simoni (Italy)
14.25 L2: Polymorphisms of LH and its receptorI. Huhtaniemi (UK)
14.50 L3: Facts and myths on the “Liasons dangerous”between LH and Progesterone C.Y. Andersen (Denmark)
15.15 Panel Discussion
16.00 Coffee break
Taking off from basic scienceSession I
9
Legend: L : Lecture;
Chairs: F. Zullo (Italy) - M. Banker (India)
16.30 L4: Is there a role for LH in elderly patients?E. Bosch (Spain)
16.55 L5: LH in low prognosis patientsC. Alviggi (Italy)
17.20 L6: LH in antagonist cycles; is the story really written?R. Orvieto (Israel)
17.45 Panel Discussion
18.30 End of the first day
Flying through literature...Session II
10
Saturday, 28 May 2016
Chairs: A. La Marca (Italy) - S.K. Sunkara (UK)
08.45 L7: The European point of view K. Buhler (Germany)
09.10 L8: The Indian point of view M. Banker (India)
09.35 L9: The Latin America approachS. C. Esteves (Brazil)
10.00 Panel discussion
10.45 Coffee break
Chairs: A. Ferraretti (Italy) - N. Colacurci (Italy)
11.15 L10: The flip side of LH R. Fanchin (France)
11.15 L11: ESHRE Bologna criteria: where are we? N. Polyzos (Greece)
11.40 L12: Matching patient and protocols in low prognosis; is it possible? P. Humaidan (Denmark)
12.30 Panel discussion
13.15 Concluding remarks
End of the conference
Closing lunch
Landing in the real worldSession III
What about next flightsSession IV
11
General information
VenueThis conference will take place at the:
Royal Continental HotelVia Partenope, 38/4480121 Napoli
LanguageThe official language of this conference will be English.
CME ProviderEXCEMED - Excellence in Medical Education
Senior Programme Manager: Chloé XilinasT +39 06 420413 505 - F +39 06 420413 [email protected]
Medical Advisor: Alessandro [email protected]
12
Registration fee The registration fee is € 350,00 and includes:• Scientific sessions• Coffee breaks and luncheons• Dinner on 27 May 2016• Educational materials• Certificate of attendance
For registration and accommodation please contact:
Event Planet srlProject Coordinator: Morena Trematerra | Paola FedericoTel: +39 (0)81.5529399 - Fax: +39 (0)[email protected]
13
Visit www.excemed.org
Keep in touch
14
https://twitter.com/EXCEMED_Repro
www.facebook.com/excemed/
www.linkedin.com/company/excemed---excellence-in-medical-education
15
Take a look at the new website
• Six specialty areas, including reproductivemedicine
• Accessible and accredited e-learning packages
• A world-class repository of CME knowledge andlearning materials
• Monthly updates about our events and resourcesin reproductive medicine
• Register with us online and access it all – free
www.excemed.org
Better outcomes for patients start here.With over 40 years in the field, EXCEMED has been delivering CME-accredited programmes longer than any other provider
in Europe, and now offers CME worldwide.
ONCOLOGY NEUROLOGY CARDIOMETABOLIC REPRODUCTIVE MEDICINEIMMUNOLOGY ENDOCRINOLOGY AND METABOLISM SPECIALTY
AREA
LIVE EVENTS LEARNING RESOURCES ONLINE COURSES NEWS
AN EXCLUSIVE FOCUSON CME
Our core mission is to help physicians achieve the best possible outcomes for patients. Our name,EXCEMED, symbolizes a drive for excellence and reflects a passion for delivering the
absolute best in CME. With four decades of achievement behind us and access to the world’spremiere medical experts, better outcomes for patients start here. About EXCEMED.
16
All EXCEMED programmes are organised solely to promote the exchangeand dissemination of scientific and medical information. No forms ofpromotional activities are permitted. This programme is made possiblethanks to an educational grant received from Merck KGaA, Darmstadt,Germany.
EXCEMED - Excellence in Medical EducationHeadquarters14, Rue du Rhône - 1204 Geneva, SwitzerlandRepresentative OfficeSalita di San Nicola da Tolentino 1/b - 00187 Rome, ItalyT +39 06 420413 1 - F +39 06 420413 677
Copyright © EXCEMED, 2016. All rights reserved.
Improving the patient's life through medical educationwww.excemed.org